CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 90 enrolled
Drug / intervention
Ropivacaine combined with methylene blue for iliac fascia blockdrug
Likely dose
Ropivacaine combined with methylene blue for iliac fascia block 30mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06284941
NCT06284941N/ACompleted

A Study of Ropivacaine Complex Methylene Blue Fascia Iliaca Compartment Block on Analgesia in Patients Undergoing Hip Arthroplasty

Wang wanxia·interventional·Posted Feb 29, 2024·Updated Feb 4, 2025

In Brief

A clinical study evaluating Ropivacaine combined with methylene blue for iliac fascia block for Femoral Neck Disease. Completed, enrolled 90 participants across 1 site.

Detailed Summary

Total hip arthroplasty is currently the most effective method for treating hip joint lesions and improving quality of life, but postoperative severe pain is not conducive to rapid recovery of patients. In recent years, the widespread application of ultrasound has achieved good clinical results in iliac fascia block for postoperative analgesia in THA. However, the use of high-dose local anesthetics can increase the risk of local anesthetic poisoning, and the single block analgesia time is generally less than 24 hours. Methylene blue, as a long-acting analgesic drug, can block the pain transmission of nerve fibers for a long time, achieving analgesic effects without damaging neurons. This study used ultrasound-guided ropivacaine combined with methylene blue to perform iliac fascia block on patients undergoing total hip replacement, with the aim of prolonging pain relief time, reducing complications, and promoting postoperative recovery on the basis of traditional methods.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedFeb 29, 2024
Enrollment StartJun 20, 2023
Primary CompletionFeb 28, 2024
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 2.3 years ago

Interventions

Ropivacaine combined with methylene blue for iliac fascia blockdrug

Ultrasound guided iliac fascia block, administered with 30ml of 0.25% ropivacaine+0.05% methylene blue